PP
BVS icon

PDT Partners’s Bioventus BVS Stock Holding History

PDT Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Sell
42,113
-13,116
-24% -$110K 0.02% 440
2025
Q4 		$411K Hold
55,229
– – 0.03% 447
2025
Q3 		$369K Hold
55,229
– – 0.02% 483
2025
Q2 		$366K Buy
55,229
+42,072
+320% +$298K 0.02% 567
2025
Q1 		$120K Buy
+13,157
New +$131K 0.01% 713

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PDT Partners's BVS Position: Q1 2026 in Review

PDT Partners reduced its Bioventus (BVS) stake by 24% in Q1 2026, selling an estimated $110K and leaving 42,113 shares worth $384K. The position accounts for 0.02% of the portfolio, ranked #440.

PDT Partners first reported a position in BVS in Q1 2025 and has held it in 5 quarters since. The position peaked at $411K in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • PDT Partners held 42,113 shares of Bioventus worth $384K as of Q1 2026.
  • PDT Partners sold 13,116 Bioventus shares in Q1 2026, an estimated $110K.
  • Bioventus made up 0.02% of PDT Partners's portfolio in Q1 2026, its #440 holding.
  • PDT Partners first reported a position in Bioventus in Q1 2025 and has held it in 5 quarters since.
  • PDT Partners's Bioventus position peaked at $411K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.